Riskpilot← Back to searchSign inGet full accessFRENCH PHARMACY ApS
APSActiveCVR 35825649Havborgvej 8Wholesale of perfume and cosmetics · NACE 4645Est. 2014— employees
Revenue 2024
DKK 470K
-37% vs 2023
EBITDA margin
100.0%
-37% vs 2023
Equity ratio
61.9%
Financial strength
Net profit 2024
DKK 305K
-51% vs 2023
| Revenue | DKK 470K | -37% |
| EBITDA | DKK 470K | -37% |
| Net profit | DKK 305K | -51% |
| Total assets | DKK 5,1M | -69% |
| Equity | DKK 3,2M | +11% |
| Employees | — | — |
Legal name
FRENCH PHARMACY ApS
CVR number
35825649
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
3. april 2014
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive virksomhed med kosmetiske behandlinger samt at drive virksomhed med handel med plejeprodukter samt al hermed beslægtet virksomhed.
Address
Havborgvej 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 138 | 801 | 431 | 750 | 470 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 138 | 801 | 431 | 750 | 470 |
| Depreciation & amort. | -6 | -11 | -16 | -17 | -24 |
| EBIT | 132 | 790 | 415 | 733 | 446 |
| Net financials | -22 | 20 | 36 | 78 | -45 |
| Profit before tax | 109 | 810 | 451 | 811 | 401 |
| Tax | 27 | 184 | 106 | 183 | 96 |
| Net profit | 82 | 625 | 344 | 628 | 305 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7.470 | 11.537 | 12.743 | 16.435 | 5.103 |
| Equity | 1.258 | 1.883 | 2.228 | 2.855 | 3.160 |
| Long-term debt | 112 | 112 | 0 | 0 | 0 |
| Short-term debt | 6.100 | 9.528 | 10.505 | 13.571 | 1.936 |
| Total debt | 6.213 | 9.640 | 10.505 | 13.571 | 1.936 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
9.6%
This company
18.4%
Market median
-48% vs market
20202024
Net profit margin
64.8%
This company
8.1%
Market median
+700% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Management | Management | 2014 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GAMMELGAARD HOLDING ESBJERG ApS
FRENCH PHARMACY ApS Board members of FRENCH PHARMACY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marianne Kyster Gammelgård | Management | 0 companies |